Dosage evidence

BPC-157 Dosage: Why There Is No Established Dose

Not FDA-approved. In a draft, non-binding policy (October 28, 2026), HHS says it does not intend to bring enforcement action against 503A compounding of BPC-157 acetate given subcutaneously, intramuscularly, orally or topically, if ten conditions are met, until FDA settles the 503A bulks list; it was in category 2 from September 2023 until April 22, 2026. FDA's earlier published concern, below, is that almost nothing is known about it in humans.

Where BPC-157 stands with the FDA

HHS 503A enforcement discretion (Oct 2026) · not approved
“FDA has identified no, or only limited, safety-related information for the proposed routes of administration. Therefore, the agency lacks sufficient information to know whether the drug would cause harm when administered to humans.”
— US Food and Drug Administration, verbatim

There is no dose to report

There is no FDA-labeled dose and no human trial we could verify that establishes one. The mcg figures that circulate for BPC-157 are extrapolated from animal work, where doses are given per kilogram of body weight in rodents and do not translate directly to a human dose; our BPC-157 weight-loss evidence review walks through those rodent studies. The draft HHS compounding policy for BPC-157 does not fill the gap, because it sets no dose.

We would rather tell you this than publish a number. Pages that rank for “bpc-157 dosage” routinely state precise-looking figures with no citation attached to them. A number without a source is not more useful than an honest absence — it is less useful, because it looks like it came from somewhere.

Convert your prescribed dose to syringe units

If a clinician has prescribed BPC-157 for you, the number that matters next is how far to draw the syringe — and that depends on how much bacteriostatic water went into the vial, not on the peptide itself.

What this does — and what it does not

This converts a dose your prescriber has already given you into a volume and a number of units on a U-100 insulin syringe. It does not suggest a dose, and it does not tell you whether a peptide is appropriate for you. Most research peptides have no FDA-approved dosing, so there is no “standard” number for us to fill in. Doses here are in micrograms (mcg) — confusing mcg with mg is a 1,000-fold error and the single most common way people get this wrong.

Enter the dose your prescriber gave you, in micrograms, to see the volume and syringe units.

Your 5 mg vial in 2 mL of bacteriostatic water is 2,500 mcg/mL.

Keep reading

References

  1. 1.US Food and Drug Administration. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks — category 2 of the interim policies, and the list of substances nominated but withdrawn. FDA Human Drug Compounding. 2026. https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks
  2. 2.US Department of Health and Human Services. HHS Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances (Appendix A: list; Appendix B: identities, routes, and justifications). HHS. 2026. https://www.hhs.gov/sites/default/files/hhs-503a-peptide-enforcement-discretion-policy-appendix-b.pdf

This page reports what regulators and published sources say about BPC-157. It is not medical advice, not a recommendation to use BPC-157, and not a dosing instruction. Every source above was opened and read on the date recorded in our data; regulatory status changes, so check the primary source before relying on it.